ISO/TC 212
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 91317 | ISO/WD TS 25725 | Design and workflow requirements for in vitro diagnostics NGS based oncology application | Izstrādē |
| 88356 | ISO/DTS 24883 | In vitro diagnostic medical devices — General Guidance for manufacturers of lateral flow immunoassay (LFIA) for rapid diagnostic testing (RDT) | Izstrādē |
| 87674 | ISO/CD 24051-2.2 | Medical laboratories — Part 2: Digital pathology and artificial intelligence (AI)-based image analysis | Izstrādē |
| 90122 | ISO/CD 21474-4 | In vitro diagnostic medical devices — Multiplex molecular testing for nucleic acids — Part 4: Detection of pathogens | Izstrādē |
| 90994 | ISO/CD TS 25646 | In vitro diagnostic medical devices — Definition of analytical performance specifications for laboratory measurements based on medical requirements | Izstrādē |
| 86743 | ISO/AWI TS 20776-3 | ISO/TS 20776-3, Clinical laboratory testing and in vitro diagnostic test systems — Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices — — Part 3: Part 3: Quality performance of disc-diffusion agar method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases | Izstrādē |
| 86739 | ISO/DTS 21385 | Recommendations for the implementation of emerging technology in medical laboratories | Izstrādē |
| 91142 | ISO/CD 15197 | In vitro diagnostic test systems — Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus | Izstrādē |
| 83899 | ISO/CD TS 8219 | Requirements for the identification and characterisation of microbes using next generation sequencing direct from clinical specimens in the management of infectious disease | Izstrādē |
| 93491 | ISO/AWI 35001 | Biorisk management for laboratories and other related organisations | Izstrādē |
Displaying 121-130 of 147 results.